Gilead Sciences Inc (GILD) earnings · P/E 18, rev $7.80B
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
This GILD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
When the next GILD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 12.1% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full GILD research stays on the stock page; the tape stays on the quote page.
Not investment advice.